KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) EBIT Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 2,500.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -91.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 395.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -4,555.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -53.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 1,031.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -9,003.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -338.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -91.00
Dec 28, 2025 3,349.00
Sep 28, 2025 281.00
Jun 29, 2025 880.00
Mar 30, 2025 630.00
Sep 29, 2024 -589.00
Jun 30, 2024 222.00
Mar 31, 2024 -191.00
Dec 31, 2023 5,188.00
Oct 1, 2023 -49.00
Jul 2, 2023 522.00
Apr 2, 2023 -62.00
Jan 1, 2023 2,847.00
Oct 2, 2022 -158.00
Jul 3, 2022 -684.00
Apr 3, 2022 -450.00
Oct 3, 2021 119.00
Jul 4, 2021 94.00
Apr 4, 2021 145.00
Jan 3, 2021 2,156.00
Sep 27, 2020 432.00
Jun 28, 2020 -623.00
Mar 29, 2020 -221.00
Dec 29, 2019 -546.00
Sep 29, 2019 -152.00
Jun 30, 2019 -408.00
Mar 31, 2019 -397.00
Dec 30, 2018 -4,527.00
Sep 30, 2018 -3.00
Jul 1, 2018 -198.00
Apr 1, 2018 -268.00
Dec 31, 2017 -693.00
Oct 1, 2017 -715.00
Jul 2, 2017 -260.00
Apr 2, 2017 -98.00
Jan 1, 2017 299.00
Oct 2, 2016 186.00
Jul 3, 2016 177.00
Apr 3, 2016 216.00
Jan 3, 2016 4,119.00
Sep 27, 2015 191.00
Jun 28, 2015 -28.00
Mar 29, 2015 249.00
Dec 28, 2014 1,234.00
Sep 28, 2014 571.00
Jun 29, 2014 810.00
Mar 30, 2014 272.00
Dec 29, 2013 -4,560.00
Sep 29, 2013 89.00
Jun 30, 2013 31.00
Mar 31, 2013 -225.00
Dec 30, 2012 1,037.00
Sep 30, 2012 -303.00
Jul 1, 2012 -64.00
Apr 1, 2012 -266.00